Literature DB >> 1568314

Diagnosis of alpha-mannosidosis by measuring alpha-mannosidase in plasma.

E M Prence1, M R Natowicz.   

Abstract

alpha-Mannosidosis is a lysosomal storage disease resulting from a deficiency of lysosomal alpha-mannosidase activity. Diagnosis of alpha-mannosidosis has traditionally been accomplished by demonstrating reduced alpha-mannosidase activity in leukocytes. We describe a new assay of alpha-mannosidase in serum or plasma that allows specific detection of the enzyme deficiency in alpha-mannosidosis with small, easily obtained sample volumes. The assay utilizes 40 microL of serum or plasma and a fluorescent substrate, 4-methylumbelliferyl-alpha-D-mannopyranoside in sodium acetate buffer, pH 4.0. The mean activity of a control population was 194 (SD 67) mU/L, whereas the activities obtained for four alpha-mannosidosis patients were 0, 17, 17, and 33 mU/L. Comparison with the standard leukocyte alpha-mannosidase assay showed this serum or plasma assay to be equally effective in diagnosing alpha-mannosidosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1568314

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.

Authors:  Arun Babu Kumar; Xinying Hong; Fan Yi; Tim Wood; Michael H Gelb
Journal:  Mol Genet Metab       Date:  2019-06-10       Impact factor: 4.797

2.  Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels.

Authors:  Oshrit Ben-David; Yael Pewzner-Jung; Ori Brenner; Elad L Laviad; Aviram Kogot-Levin; Itai Weissberg; Inbal E Biton; Reut Pienik; Elaine Wang; Samuel Kelly; Joseph Alroy; Annick Raas-Rothschild; Alon Friedman; Britta Brügger; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

3.  Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.

Authors:  Yu Wang; Jun Ye; Wen-Juan Qiu; Lian-Shu Han; Xiao-Lan Gao; Li-Li Liang; Xue-Fan Gu; Hui-Wen Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-06-05       Impact factor: 6.150

4.  Selective screening for detection of mucopolysaccharidoses in Malaysia; A two-year study (2014-2016).

Authors:  Affandi Omar; Julaina A Jalil; Norashareena M Shakrin; Lock H Ngu; Zabedah M Yunus
Journal:  Mol Genet Metab Rep       Date:  2019-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.